Long-term adherence, safety, and efficacy of repeated onabotulinumtoxinA over five years in chronic migraine prophylaxis.

Haralabos P KalofonosEmmanouil V DermitzakisGeorge S VlachosMichail Vikelis

Published in: Acta neurologica Scandinavica (2022)

Considerably high adherence, considerable satisfaction and sustained safety/efficacy were observed in patients followed up for five years, supporting a favorable benefit/risk profile for consistently delivering long-term BoNTA in CM.

Keyphrases

ejection fraction
newly diagnosed
type diabetes
patient reported outcomes
drug induced
weight loss
patient satisfaction